LILLY FDA Approval NDA 050550

NDA 050550

LILLY

FDA Drug Application

Application #050550

Application Sponsors

NDA 050550LILLY

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued008

Application Products

001INJECTABLE;INJECTIONEQ 250MG BASE/VIAL0MOXAMMOXALACTAM DISODIUM
002INJECTABLE;INJECTIONEQ 500MG BASE/VIAL0MOXAMMOXALACTAM DISODIUM
003INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0MOXAMMOXALACTAM DISODIUM
004INJECTABLE;INJECTIONEQ 2GM BASE/VIAL0MOXAMMOXALACTAM DISODIUM
008INJECTABLE;INJECTIONEQ 10GM BASE/VIAL0MOXAMMOXALACTAM DISODIUM

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50550
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.